In the BioHarmony Drug Report Database

"Preview" Icon

Mitotane

Lysodren (mitotane) is a small molecule pharmaceutical. Mitotane was first approved as Lysodren on 1982-01-01. It is used to treat adrenocortical carcinoma and cushing syndrome in the USA. It has been approved in Europe to treat adrenal cortex neoplasms. It is known to target cholesterol side-chain cleavage enzyme, mitochondrial and cytochrome P450 11B1, mitochondrial.

 

Trade Name

 

Lysodren
 

Common Name

 

mitotane
 

ChEMBL ID

 

CHEMBL1670
 

Indication

 

adrenal cortex neoplasms, adrenocortical carcinoma, cushing syndrome
 

Drug Class

 

Image (chem structure or protein)

Mitotane structure rendering